Synim Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 45.20%
(FY 2020)
- Profit 9.64%
(FY 2020)
- Ebitda 40.30%
(FY 2020)
- Net Worth 86.12%
(FY 2020)
- Total Assets 56.72%
(FY 2020)
About Synim Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Siva Siddam, Seshapani Kotra, Juturi Swamy, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2017PTC115968
- Company No.
115968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Synim Remedies?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sambu Krishna  | Director | 20-Jul-2021 | Current |
| Siva Siddam | Director | 17-Mar-2017 | Current |
| Seshapani Kotra | Director | 17-Mar-2017 | Current |
| Juturi Swamy | Director | 20-Jul-2021 | Current |
| Juturi Lakshmi | Director | 20-Jul-2021 | Current |
| Latha Sambu | Director | 20-Jul-2021 | Current |
Financial Performance of Synim Remedies.
Synim Remedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 45.2% increase. The company also saw a slight improvement in profitability, with a 9.64% increase in profit. The company's net worth Soared by an impressive increase of 86.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synim Remedies?
In 2019, Synim Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synim Remedies?
Unlock and access historical data on people associated with Synim Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synim Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synim Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
